Clinical Trial Update: Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating intra-tumoral injections of vvDD-hIL2-2-RG-1 for metastatic gastric, esophageal, liver, colorectal, and peritoneal cancers; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Liver Cancer
• Peritoneal Cancer
• Peritoneal Metastases

Drugs mentioned

• vvDD-hIL2-2-RG-1 (vvDD-hIL2-2-RG-1)

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: Gastric Neoplasms, Esophageal Cancer | Phase 1 | Status: RECRUITING